Understood, but how many times have we been disappointed with our assumptions on their timely execution of things? ;) We have all tempered our expectations over the last 18 months. So I wouldn’t give them too much credit!
What gives you this impression that they have applied under project Orbis? Wouldn’t you PR that if the application was accepted? Why would they keep such a significant milestone away from shareholders while PR first compassionate use patient news?
All I am saying is be prepared to temper your expectations again!
Market Data 
Markets 
AI
